机构:[1]Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute, BeijingChildren’s Hospital, Capital Medical University, National Center for Children’sHealth, Beijing, China科研平台职能科室临床流行病与循证医学中心儿科研究所首都医科大学附属北京儿童医院[2]Beijing Key Laboratory of Pediatric Hematology Oncology National Key Discipline of Pediatrics, Capital Medical University Key Laboratory of Major Diseases in Children, Ministry of Education Hematology Oncology Center, Beijing Children’s Hospital, Capital Medical University, National Centerfor Children’s Health, Beijing, China医技科室职能科室临床流行病与循证医学中心血液中心首都医科大学附属北京儿童医院[3]Beijing Advanced Innovation Center forBig Data-Based Precision Medicine, Beihang University & Capital MedicalUniversity, Beijing, China.
第一作者机构:[1]Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute, BeijingChildren’s Hospital, Capital Medical University, National Center for Children’sHealth, Beijing, China
通讯作者:
通讯机构:[1]Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute, BeijingChildren’s Hospital, Capital Medical University, National Center for Children’sHealth, Beijing, China[2]Beijing Key Laboratory of Pediatric Hematology Oncology National Key Discipline of Pediatrics, Capital Medical University Key Laboratory of Major Diseases in Children, Ministry of Education Hematology Oncology Center, Beijing Children’s Hospital, Capital Medical University, National Centerfor Children’s Health, Beijing, China[3]Beijing Advanced Innovation Center forBig Data-Based Precision Medicine, Beihang University & Capital MedicalUniversity, Beijing, China.[*1]Hematology Oncology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, 56 Nan Lishi Road, Xicheng District, Beijing 100045, China[*2]Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, 56 Nan Lishi Road, Xicheng District, Beijing 100045, China
推荐引用方式(GB/T 7714):
Lei Cui,Li Zhang,Hong-Hao Ma,et al.Circulating cell-free BRAFV600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis.[J].Haematologica.2020,doi:10.3324/haematol.2019.229187.
APA:
Lei Cui,Li Zhang,Hong-Hao Ma,Chan-Juan Wang,Dong Wang...&Rui Zhang.(2020).Circulating cell-free BRAFV600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis..Haematologica,,
MLA:
Lei Cui,et al."Circulating cell-free BRAFV600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis.".Haematologica .(2020)